Microbiologics rapidly evolving in the virology industry
Share
Tweet
February 24, 2019
ST. CLOUD, Minn. (AP) — Microbiologics entered into the virology industry only a little more than one year ago, but the St. Cloud-based biomaterial manufacturer is already making a big impact in the world of viruses and vaccines.
Microbiologics acquired San Diego-based Virapur at the end of 2017, allowing the company to expand its research and development support services to vaccines and gene therapy.
"We've more than doubled the business in the first year that we've had it, so it's very exciting for us," Microbiologics CEO Brad Goskowicz told the St. Cloud Times of the acquisition. "In the pa...
For access to this article please
sign in or
subscribe.
Reader Comments(0)